NetScientific (NSCI) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 Feb 2023 07:00 AM
RNS
Related party loan to ProAxsis Limited
27 Feb 2023 03:28 PM
RNS
PDS completes FDA meeting for triple combination
10 Feb 2023 02:05 PM
RNS
Second Price Monitoring Extn
10 Feb 2023 02:00 PM
RNS
Price Monitoring Extension
10 Feb 2023 11:05 AM
RNS
Second Price Monitoring Extn
10 Feb 2023 11:00 AM
RNS
Price Monitoring Extension
01 Feb 2023 07:00 AM
RNS
Board Change
03 Jan 2023 01:31 PM
RNS
PDS Announces Exclusive Global License Agreement
28 Dec 2022 03:05 PM
RNS
PDS Biotech: Median Overall Survival announcement
16 Dec 2022 07:00 AM
RNS
PDS: HPV16 Head and Neck Cancer announcement
12 Dec 2022 02:00 PM
RNS
Board Changes; Options; Co-Investment Agreement
29 Nov 2022 07:00 AM
RNS
EMV C leads £4.2m round in 5G and SATCOM leader
14 Nov 2022 02:50 PM
RNS
PDS Q3 Results and Business Update
14 Nov 2022 02:05 PM
RNS
Second Price Monitoring Extn
14 Nov 2022 02:00 PM
RNS
Price Monitoring Extension
09 Nov 2022 07:00 AM
RNS
Board Change
07 Nov 2022 03:40 PM
RNS
PDS reports presentation of data at cancer society
20 Oct 2022 07:00 AM
RNS
EMV Capital secures investment in Ventive
11 Oct 2022 04:00 PM
RNS
PDS Update
03 Oct 2022 01:56 PM
RNS
PDS completes End-of-Phase 2 meeting with FDA
30 Sep 2022 07:00 AM
RNS
Half-year Report
25 Aug 2022 07:00 AM
RNS
PDS Completes $35 Million Financing Agreement
16 Aug 2022 07:00 AM
RNS
Acquisition of 30% Vortex stake & new Vortex CEO
08 Aug 2022 04:45 PM
RNS
PDS Reports Q2 2022 Results & Business Update
29 Jun 2022 02:05 PM
RNS
Result of AGM
28 Jun 2022 09:15 AM
RNS
Holding(s) in Company
27 Jun 2022 08:30 AM
RNS
Holding(s) in Company
27 Jun 2022 08:30 AM
RNS
Director/PDMR Shareholding
22 Jun 2022 07:00 AM
RNS
Result of Placing and Total Voting Rights
21 Jun 2022 04:41 PM
RNS
Proposed Placing to raise at least £1.5 million
17 Jun 2022 12:00 PM
RNS
NetScientific to increase Q-Bot stake to 23.7%
15 Jun 2022 07:00 AM
RNS
Q-Bot secures £1.6m of investment to fund growth
07 Jun 2022 11:07 AM
RNS
Notice of AGM and Annual Report & Accounts
06 Jun 2022 07:00 AM
RNS
PDS Granted FDA Fast Track Designation for PDS0101
27 May 2022 02:39 PM
RNS
PDS Biotech - new data for ongoing clinical trials
19 May 2022 07:00 AM
RNS
General Counsel Strategic Hire & Grant of Options
16 May 2022 07:00 AM
RNS
ProAxsis Update
12 May 2022 07:00 AM
RNS
Final Results
11 May 2022 03:46 PM
RNS
PDS Reports Q1 2022 Results & Business Update
09 May 2022 07:00 AM
RNS
Notice of Results & Investor Presentation
06 May 2022 07:00 AM
RNS
Acquisition of 30% of Vortex Biotech Holdings
25 Apr 2022 02:05 PM
RNS
Second Price Monitoring Extn
25 Apr 2022 02:00 PM
RNS
Price Monitoring Extension
25 Apr 2022 11:05 AM
RNS
Second Price Monitoring Extn
25 Apr 2022 11:00 AM
RNS
Price Monitoring Extension
31 Mar 2022 01:24 PM
RNS
PDS Provides Business Update & Full-Year Results
04 Mar 2022 07:30 AM
RNS
Publication of Shareholder Newsletter
24 Feb 2022 04:45 PM
RNS
PDS Announces Preliminary Safety Data on PDS0101
15 Feb 2022 02:32 PM
RNS
PDS Clinical Trial with Mayo Clinic
02 Feb 2022 03:00 PM
RNS
PDS Phase 2 Trial Update
UK 100

Latest directors dealings